Original CommunicationsOpen versus endoscopic carpal tunnel release: A decision analysis*,* *,*,* *,♢
Section snippets
Specification of the model
We designed a decision—analytic model to examine the differences between the open and endoscopic methods, incorporating all the major possible outcomes of each procedure. Since the cost of care before surgery should not differ between the open and endoscopic methods, a decision—analytic model was developed beginning at the point of surgical intervention. An end point of 1 year was established to allow patients to reach a medical end result. The model consists of branches for each possible
Base case estimate
Using the base assumptions of the model, the overall cost of the open technique was $6,315 compared with $5,896 for the endoscopic technique. Thus, the approaches had similar total costs, with endoscopic technique approximately 7% less costly than the open technique in the base case.
Sensitivity analyses
Sensitivity analyses were performed to examine the effects of varying values of individual cost components and probabilities on total cost. The analyses varied one variable while holding the other variables constant
Discussion
The purpose of this decision analysis was to use data obtained in prior clinical studies to examine whether the potential savings in lost wages due to the faster return to work often associated with the endoscopic technique are outweighed by the costs of a higher complication rate. The principal findings of the analysis are that the costs of the procedures are similar and that the cost differential is highly sensitive to 2 key variables: the rate of complications associated with endoscopic
References (18)
- et al.
Analysis of pinch and grip strength after carpal tunnel release
J Hand Surg
(1989) - et al.
Long-term analysis of patients having surgical treatment for carpal tunnel syndrome
J Hand Surg
(1986) - et al.
Complications of surgical release for carpal tunnel syndrome
J Hand Surg
(1978) - et al.
Endoscopic release of the carpal tunnel: a randomized prospective multicenter study
J Hand Surg
(1992) - et al.
A prospective, randomized study with an independent observer comparing open carpal tunnel release with endoscopic carpal tunnel release
J Hand Surg
(1996) Endoscopic release of the carpal ligament for carpal tunnel syndrome: 22-month clinical result
Arthroscopy
(1990)- et al.
Endoscopic carpal tunnel release
J Hand Surg
(1992) - et al.
Deep postoperative wound infection after carpal tunnel release
J Hand Surg
(1989) - et al.
Endoscopic carpal tunnel release: a prospective study of complications and surgical experience
J Hand Surg
(1995)
Cited by (54)
Evaluation of Factors Affecting Return to Work Following Carpal Tunnel Release: A Statewide Cohort Study of Workers' Compensation Subjects
2022, Journal of Hand SurgeryCitation Excerpt :Net medical costs over the first 6 months after surgery were 20.7% greater for individuals undergoing ECTR, which is consistent with multiple studies.47–50 A 1999 cost-effectiveness analysis found that DOOW after ECTR would need to be 21 days less than OCTR to be less costly to the patient.51 If that conclusion were to hold, our findings would indicate that ECTR may not be cost effective in a WC population.
Endoscopic Versus Open Carpal Tunnel Release: A Detailed Analysis Using Time-Driven Activity-Based Costing at an Academic Medical Center
2019, Journal of Hand SurgeryCitation Excerpt :Unfortunately, extrapolation of fee and charge data do not result in an accurate definition of patient level costs owing to the intricate involvement of third-party payer systems. One further study identified that the societal cost burden of CTR was sensitive to the incidences of perioperative complications as well as the duration of work absence secondary to lost wages; however, the study was completed with certain assumptions—including a lack of cost differential between the 2 procedural interventions—which can reasonably be called into question.19 Altogether, the existing body of cost analysis literature comparing endoscopic versus open CTR has not yet been able to define detailed costs across all phases of a patient’s care cycle as can be achieved with TDABC.
Our Surgical Experience: Open Versus Endoscopic Carpal Tunnel Surgery
2018, Journal of Hand SurgeryCitation Excerpt :There was a marginal benefit (for all age groups) of cost for ECTR versus OCTR, which was feasible in the hypothetical case in which the rate of median nerve injury was 1% lower for ECTR versus OCTR surgery (this has not been reported in the literature). Vasen et al12 acknowledged societal costs associated with ECTR versus OCTR and cited complication rates of 5% for ECTR versus 0.1% for OCTR and the return to work time of 28 days for ECTR versus 54 for OCTR. They presented an algorithm highlighting the cost of outcomes, from $6,288 for an open surgery without complication to $701,609 for an endoscopic surgery that resulted in severe nerve laceration.
Update on carpal tunnel syndrome
2013, FMC Formacion Medica Continuada en Atencion PrimariaOpen Versus Endoscopic Carpal Tunnel Release
2012, Orthopedic Clinics of North AmericaCitation Excerpt :However, the incidence of major nerve complications, as discussed earlier, is likely similar when comparing the 2 groups outright. Vasen and colleagues39 performed a decision analysis that used a direct cost basis, and applied data to a model using assumptions of risks for complications. Using their model, a complication rate of greater than 6.2% would favor OCTR, a return-to-work difference of less than 21 days would favor OCTR, and a greater than 0.1% incidence of major nerve injury would favor OCTR.
Endoscopic Versus Open Carpal Tunnel Release
2009, Journal of Hand SurgeryCitation Excerpt :This argues that ECTR is more cost-effective for employed patients. Vasen et al. estimated the costs of the ECTR versus the OCTR procedures, also accounting for differences in lost wages from time off work and the cost of complications and their treatment.38 A decision analytic model was used, incorporating the outcomes and rates of various complications from existing literature.
- *
Supported by National Institutes of Health Grant No. AR36308 and the Arthritis Foundation.
- * *
No benefits in any form have been received or will be received from a commercial party related directly or indirectly to the subject of this article.
- *
Reprint requests: Jeffrey N. Katz, MD, Rheumatology Division, Brigham and Women's Hospital, 75 Francis St, Boston, MA 02115.
- * *
J Hand Surg 1999;24A:1109–1117.
- ♢
0363-5023/99/24A05-0016$3.00/0